Muted end to FY20, promising FY21 pipeline
22/02/21 -"Smith & Nephew reported an in line Q4/FY20 top line (-7.1%/-12.1%). The Q4 decline was attributable to other reconstruction (-45.6%), knees (-16.2%) and ENT (-33.1%), while Hips surprised with a ..."
Pages
67
Language
English
Published on
22/02/21
You may also be interested by these reports :
20/10/26
EssilorLuxottica recorded strong growth in Q3 2026, ahead of market expectations, with revenue up 9.0% YoY and 7.2% at constant currency. Management ...
15/10/26
Dräger’s Q3 26 prelims were soft, with sales and EBIT 1.3% and 8.4% below our estimates. EBIT included €20.1m of customs refunds; excluding these, ...
13/10/26
Demant reported robust preliminary Q3 sales figures, driven by strong demand for its newly launched hearing aids. The 2026 guidance has been revised ...
09/10/26
Our target price has been revised downwards due to updated estimates following management’s decision to lower the upper end of its topline guidance ...